Literature DB >> 2529158

Comparison of high- and low-diabetes-incidence NOD mouse strains.

A G Baxter1, M A Adams, T E Mandel.   

Abstract

The nonobese diabetic (NOD) mouse is a model of insulin-dependent diabetes mellitus. These mice develop insulinopenia and hyperglycemia secondary to beta-cell destruction, which is associated with insulitis and autoantibody production. We have two strains of NOD mice: a low-incidence strain (NOD/Wehi), in which less than 10% females and less than 1% males develop diabetes by 150 days despite intense insulitis, and a high-incidence strain (NOD/Lt), in which most females and many males develop diabetes by 150 days. This phenotypic difference has been maintained for 24 mo despite identical housing in our specific pathogen-free unit. Reciprocal skin grafting and allozyme electrophoresis have not identified a difference between the strains. Mixed-lymphocyte cultures were performed with splenic T-lymphocytes cultured with equal numbers of irradiated stimulator splenocytes for 3-6 days. NOD/Wehi mice demonstrated a heightened syngeneic mixed-lymphocyte response (SMLR), averaging 19% of the allogeneic response to CBA/CaHWehi cells. The response to NOD/Lt stimulator cells was not significantly different from the syngeneic response. In contrast, NOD/Lt mice had an SMLR similar to that of BALB/cAnBradleyWehi control mice, averaging 5% of the allogeneic response. NOD/Lt cells also responded similarly to NOD/Wehi stimulator cells and briskly to allogeneic cells. The heightened SMLR in NOD/Wehi mice may reflect active generation of suppressor function, and this may account for the low incidence of diabetes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529158     DOI: 10.2337/diab.38.10.1296

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

1.  Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-gamma antibody.

Authors:  T W Kay; I L Campbell; L Oxbrow; L C Harrison
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

2.  The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse.

Authors:  V Ablamunits; D Elias; I R Cohen
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

3.  Prevention of spontaneous and cyclophosphamide-induced diabetes in non-obese diabetic (NOD) mice with oral 2-acetyl-4-tetrahydroxybutylimidazole (THI), a component of caramel colouring III.

Authors:  T E Mandel; M Koulmanda; I R Mackay
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

4.  Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.

Authors:  N Chosich; L C Harrison
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

5.  Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer.

Authors:  M J Clare-Salzler; J Brooks; A Chai; K Van Herle; C Anderson
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

Review 6.  Type 1 diabetes mellitus: an imbalance between effector and regulatory T cells?

Authors:  E J Rashba; E P Reich; C A Janeway; R S Sherwin
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

7.  Insulitis in transgenic mice expressing tumor necrosis factor beta (lymphotoxin) in the pancreas.

Authors:  D E Picarella; A Kratz; C B Li; N H Ruddle; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

8.  Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice.

Authors:  I L Campbell; T W Kay; L Oxbrow; L C Harrison
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

9.  Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice.

Authors:  A G Baxter; A C Horsfall; D Healey; P Ozegbe; S Day; D G Williams; A Cooke
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

10.  Accelerated diabetes in non-obese diabetic (NOD) mice differing in incidence of spontaneous disease.

Authors:  A G Baxter; T E Mandel
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.